Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales ...

Canada's researchers, businesses and institutions are at the forefront of the genomics revolution, unlocking the potential of this transformative science to drive innovation across industries, address ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

The strategy is backed with $175.1 million CAD in federal funding to be dispensed over the next seven years through ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...

Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating ...

The Government of Canada is making a major push into genomics, investing $175.1 million to turn cutting-edge research into real-world breakthroughs in healthcare, agriculture, and clean technology.